STAT

Disease modelers gaze into their computers to see the future of Covid-19, and it isn’t good

Like weather forecasters, modelers who project how bad a disease outbreak might become are used to uncertainties and incomplete data, and Covid-19 has those everywhere you look.
SARS-CoV-2, the virus that causes Covid-19.

At least 550,000 cases. Maybe 4.4 million. Or something in between.

Like weather forecasters, researchers who use mathematical equations to project how bad a disease outbreak might become are used to uncertainties and incomplete data, and Covid-19, the disease caused by the new-to-humans coronavirus that began circulating in Wuhan, China, late last year, has those everywhere you look. That can make the mathematical models of outbreaks, with their wide range of forecasts, seem like guesswork gussied up with differential equations; the eightfold difference in projected Covid-19 cases in Wuhan, calculated by a team from the U.S. and Canada, isn’t unusual for the early weeks of an outbreak of a never-before-seen illness.

But infectious-disease models have been approximating reality better and better in recent years, thanks to a better understanding of everything from how germs behave to how much time people spend on buses.

“Year by year there have been improvements in forecasting models and the way they are combined to provide forecasts,” said physicist Alessandro Vespignani of Northeastern University, a leading infectious-disease modeler.

Read more: Experts envision two scenarios if the new coronavirus isn’t contained

That’s not to say there’s not room for improvement. The key variables of most models are mostly the same ones epidemiologists

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Moderna R&D Cuts, Lilly Plant Investments And More
Rise and shine, everyone, another busy day is on the way. However, this is also shaping up as a beautiful day as well, despite forecasts predicting rising heat. The skies…
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An AstraZeneca Bladder Cancer Drug, Genentech Anxiety, And More
An AstraZeneca immunotherapy improved survival rates in patients with bladder cancer, results that could reshape treatment of muscle-invasive tumors.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Vaxcyte Vaccine, Ozempic Shortages, And More
Vaxcyte shares rocketed up 36% on data showing its pneumococcal vaccine outperformed Pfizer’s Prevnar in a small trial.

Related Books & Audiobooks